Harbour Trust & Investment Management Co lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 84.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,249 shares of the healthcare conglomerate's stock after selling 12,460 shares during the quarter. Harbour Trust & Investment Management Co's holdings in UnitedHealth Group were worth $742,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH bought a new position in UnitedHealth Group during the 2nd quarter valued at $340,000. Flow Traders U.S. LLC bought a new position in shares of UnitedHealth Group during the second quarter valued at about $356,000. Finally, Jump Financial LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $377,000. 87.86% of the stock is owned by institutional investors.
Trending Headlines about UnitedHealth Group
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Q1 beat and outlook raise — UNH reported stronger-than-expected Q1 results (EPS beat, $111.7B revenue) and raised 2026 adjusted EPS guidance, which investors interpreted as evidence the turnaround is underway. VIEW: UnitedHealth's strong first quarter, forecast raise cheer Wall Street (Reuters)
- Positive Sentiment: Analyst upgrades and target hikes — Several firms (Argus, Oppenheimer, RBC, Wells Fargo, Morgan Stanley and others) raised ratings/targets after the quarter, signaling broader buy-side confidence and providing further upside signals for the stock. These Analysts Increase Their Forecasts On UnitedHealth After Upbeat Earnings (Benzinga)
- Positive Sentiment: AI and operational investments — Management announced meaningful AI spending (reported ~$1.5B) and expansion of Optum Real transaction processing, positioning Optum as a higher-throughput, margin-enhancing platform over time. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare (PYMNTS)
- Positive Sentiment: Bullish options flow — Unusually large call buying was recorded (roughly 164k calls), suggesting short-term investor optimism or hedging ahead of follow-through. (No direct article link available)
- Neutral Sentiment: Rural health initiative — The company launched a broad rural-health program to serve underserved communities; positive for long-term growth/PR but unlikely to move near-term earnings materially. UnitedHealth Launches Broad Rural Health Initiative (InsiderMonkey)
- Neutral Sentiment: Industry/peer lift — Strong UNH results boosted sentiment across insurers (CVS, Humana, Centene), but sector moves may contain idiosyncratic risks tied to medical-cost trends and policy. UnitedHealth Sets Sights on AI, Climbs (Yahoo Finance)
- Negative Sentiment: Policy/program uncertainty — UnitedHealth flagged challenges with a Medicare obesity-drug pilot, creating uncertainty about participation and near-term costs related to new drug coverage programs. UnitedHealth flags challenges in Medicare obesity drug pilot (Reuters)
- Negative Sentiment: Residual analyst caution — A few firms still express caution (e.g., Robert W. Baird maintains an underperform view with a lower target), reflecting lingering concerns about execution and medical-cost volatility. Analyst note listing (Benzinga)
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on UNH. UBS Group reduced their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a research report on Wednesday, January 28th. Jefferies Financial Group lifted their target price on UnitedHealth Group from $340.00 to $373.00 and gave the company a "buy" rating in a report on Monday. Piper Sandler reissued an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. KeyCorp reaffirmed an "overweight" rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Finally, Truist Financial reaffirmed a "buy" rating and issued a $395.00 target price (up from $370.00) on shares of UnitedHealth Group in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average target price of $377.68.
Read Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Performance
UnitedHealth Group stock opened at $353.51 on Thursday. The company has a market capitalization of $320.88 billion, a PE ratio of 26.70, a P/E/G ratio of 1.53 and a beta of 0.40. The firm has a fifty day simple moving average of $290.76 and a two-hundred day simple moving average of $317.09. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $438.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. The business had revenue of $111.65 billion for the quarter, compared to analysts' expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business's quarterly revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 18.43 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, March 9th. UnitedHealth Group's payout ratio is currently 67.02%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.